Biolargo, Inc. (BLGO)
BLGO is quoted over the counter, not listed on an exchange. Biolargo, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | BLGO, quoted over the counter |
| SEC CIK | 0000880242 |
| OTC Markets tier | OTCQX (price source, 2026-11-13) |
| SEC industry code | Chemicals & Allied Products |
| Business address | Westminster, CA |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "The foregoing factors raise substantial doubt about our ability to continue as a going concern, unless we are able to increase revenues, generate cash from operations, and/or generate cash from financing activities." | 10-Q 2026-08-14 |
| Cash and burn | $2.2M cash; operating cash flow -$2.6M a quarter. | Report 2026-06-30 |
| Shares outstanding | 328,731,362 (2026-08-12); 308,989,058 a year earlier; 288,073,533 three years earlier. | Cover page 2026-08-12 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Hacker, Johnson & Smith PA, Tampa, Florida, United States | PCAOB Form AP 2026-04-06 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $1.2M | -$4.0M | -$3.1M | $2.2M | No debt tags | $4.1M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $1.1M | -$3.4M | -$2.9M | $4.1M | No debt tags | $5.6M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $617K | -$4.1M | -$1.6M | $3.9M | $2.1M | $7.8M | 10-K 2026-03-04 |
| Q3 2025 2025-09-30 | $1.1M | -$7.2M | -$2.8M | $4.5M | $83K | $10.8M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $2.8M | -$1.9M | -$2.1M | $3.5M | $83K | $14.1M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $3.3M | -$1.9M | -$1.8M | $2.6M | No debt tags | $16.3M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $3.7M | -$1.7M | -$1.9M | $3.5M | $1.1M | $17.8M | 10-K 2026-03-04 |
| Q3 2024 2024-09-30 | $4.4M | -$1.1M | -$1.6M | $3.9M | $246K | $18.5M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-04-17 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-11-02 |
| Latest proxy | DEF 14A | 2026-10-19 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier